Welcome to Flow Pharma Inc.

Page Loading...


Research Publications

  1. P.E. Harris, T. Brasel, C. Massey, C.V. Herst, S. Burkholz, P. Lloyd, T. Blankenberg, 
    T.M. Bey, R. Carback, T. Hodge, S. Ciotlos, L. Wang, J.E. Comer, R. Rubsamen. A synthetic peptide CTL vaccine targeting nucleocapsid confers protection from SARS-CoV-2 challenge in rhesus macaques. 2021 PREPRINT. [PDF]
  2. S.  Burkholz, S. Pokhrel, B.R. Kraemer, D. Mochly-Rosen, R. Carback, T. Hodge, P. Harris, S. Ciotlos, L. Wang, C.V. Herst, R. Rubsamen. Paired SARS-CoV-2 Spike Protein Mutations Observed During Ongoing SARS-CoV-2 Viral Transfer from Humans to Minks and Back to Humans. 2021 PREPRINT. [PDF]
  3. R. Rubsamen, S. Burkholz, C. Massey, T. Brasel, T. Hodge, L. Wagn, C.V. Herst, R. Carback, P. Harris. Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome. Frontiers in Pharmacology, Volume 11, 2020. [PDF] [Publisher Website]
  4. C.V. Herst, S. Burkholz, J. Sidney, A. Sette, P.E. Harris, S. Massey, T. Brasel, E. Cunha-Neto, D.S. Rosa, W.C.H. Chao, R. Carback, T. Hodge, L. Wang, S. Ciotlos, P. Lloyd, R. Rubsamen, An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design, Vaccine, Volume 38, Issue 28, 2020, Pages 4464-4475. [PDF] [Publisher Website]
  5. R.M. Rubsamen, C.V. Herst, P.M. Lloyd, D.E. Heckerman, Eliciting cytotoxic T-lymphocyte responses from synthetic vectors containing one or two epitopes in a C57BL/6 mouse model using peptide-containing biodegradable microspheres and adjuvants, Vaccine, Volume 32, Issue 33, 2014, Pages 4111-4116, ISSN 0264-410X. [PDF] [Publisher Website]
  6. Cunha-Neto, E., Rosa, D. S., Harris, P. E., Olson, T., Morrow, A., Ciotlos, S., et al. (2017). An approach for a synthetic CTL vaccine design against Zika flavivirus using class I and class II epitopes identified by computer modeling. Front. Immunol. 8:640. [PDF] [Publisher Website]
  7. Stall AC, Becker E, Ludwig SC, Gelb D, Poelstra KA. Reduction of postoperative spinal implant infection using gentamicin microspheres. Spine (Phila Pa 1976) 2009;34:479–483. [PDF] [Author Website]